Accelerative effect of polaprezinc on healing gastric ulcer after eradication of Helicobacter pylori infection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1080220077

Enrollment

300

Registered

2005-09-08

Start date

2005-09-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric ulcer with Helicobacter pylori infection

Interventions

investigational material(s) Generic name etc : Polaprezinc INN of investigational material : Therapeutic category code : 232 Agents for peptic ulcer Dosage and Administration for Investigational mate

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria -active gastric ulcer -single gastric ulcer Exclusion criteria -the patients who are eradicated Helicobacter pylori before

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The time for healing of gastric ulcer	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026